Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

An approach to cutaneous changes caused by hematologic malignancies.

W W Piette1

  • 1University of Iowa College of Medicine, Iowa City.

Dermatologic Clinics
|July 1, 1989
PubMed
Summary

Cutaneous lesions are common in hematologic malignancies, but diagnosis is complex due to varied presentations and evolving classifications. This review groups skin findings by cell type and tumor subset for clarity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endothelial protein C activation in meningococcal sepsis.

The New England journal of medicine·2002
Same author

Cutaneous angiosarcoma.

Advances in dermatology·2002
Same author

Antimalarials.

Dermatologic clinics·2001
Same author

Severe acquired functional protein S deficiency and skin necrosis in a patient with ANCA-associated vasculitis.

Thrombosis and haemostasis·2000
Same author

Erythematous plaques due to platelet plugging: a clue to underlying myeloproliferative disorder.

Journal of the American Academy of Dermatology·2000
Same author

Antiphospholipid antibody syndrome: the problems and the promise.

The British journal of dermatology·2000

Area of Science:

  • Hematology
  • Dermatology
  • Oncology

Background:

  • Cutaneous lesions frequently manifest in hematologic malignancies.
  • Diagnosis is challenging due to diverse clinical presentations and evolving cancer classifications.
  • The classification of T-cell malignancies is expanding, incorporating disorders previously attributed to other cell types.

Purpose of the Study:

  • To provide a structured overview of cutaneous manifestations in hematologic malignancies.
  • To aid in the diagnosis of skin lesions associated with blood cancers.
  • To clarify the relationship between specific hematologic disorders and their skin findings.

Main Methods:

  • Review of clinical and histopathologic features of cutaneous hematologic malignancies.
  • Grouping of skin findings based on presumed cellular origin (T-cell, B-cell, etc.).
  • Categorization of lesions by clinical tumor subset.

Main Results:

  • Hematologic malignancies present with a wide spectrum of cutaneous lesions.
  • Shared clinical and histopathologic features can occur across dissimilar malignancies.
  • Distinctive features aid in differentiating between various hematologic skin disorders.

Conclusions:

  • A systematic approach, grouping by cell type and tumor subset, can simplify the diagnosis of cutaneous hematologic malignancies.
  • Understanding the evolving landscape of hematologic malignancy classification is crucial for accurate dermatologic diagnosis.
  • Emphasis on unique and shared features aids in distinguishing between various malignant skin conditions.

Related Experiment Videos